GlassScriptPhysician profile
Saied Talaie
NPI 1831233840
$488.64
in general payments reported to CMS, 2019-2025
9 companies · none reported in 2025
See the full distribution for Plastic and Reconstructive Surgery
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $141 · 2021: $176 · 2022: $172.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acelrx Pharmaceuticals, INC. | $124.88 | 2020 | |
| Ucb, INC. | $100.78 | 2021-2022 | |
| Medtronic, INC. | $80.00 | 2021 | |
| Regeneron Healthcare Solutions, INC. | $52.05 | 2022 | |
| Sun Pharmaceutical Industries INC. | $46.81 | 2021-2022 | |
| Abbvie INC. | $26.36 | 2021 | |
| Leo Pharma INC. | $21.76 | 2021 | |
| Lilly USA, LLC | $19.86 | 2021 | |
| Amgen INC. | $16.14 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Saied Talaie listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.